Literature DB >> 12183269

Functional characterization of Brucella melitensis NorMI, an efflux pump belonging to the multidrug and toxic compound extrusion family.

Martine Braibant1, Laurence Guilloteau, Michel S Zygmunt.   

Abstract

Two putative proteins (NorMI and NorMII) similar to the multidrug efflux protein NorM of Vibrio parahaemolyticus are encoded by the Brucella melitensis 16 M genome. We show that a drug-hypersusceptible Escherichia coli strain overexpressing NorMI displays increased resistance to norfloxacin, ciprofloxacin, gentamicin, tetraphenylphosphonium ion, acriflavine, and berberine. This elevated resistance was proven to be mediated by an energy-dependent efflux mechanism. NorMI belongs to the multidrug and toxic compound extrusion family and is the first multidrug efflux protein identified in Brucella spp.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183269      PMCID: PMC127400          DOI: 10.1128/AAC.46.9.3050-3053.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  Increasing resistance of Brucellae to co-trimoxazole.

Authors:  A Kinsara; A Al-Mowallad; A O Osoba
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

2.  Co-trimoxazole resistant Brucella.

Authors:  R M Bannatyne; M Rich; Z A Memish
Journal:  J Trop Pediatr       Date:  2001-02       Impact factor: 1.165

3.  The multidrug efflux protein NorM is a prototype of a new family of transporters.

Authors:  M H Brown; I T Paulsen; R A Skurray
Journal:  Mol Microbiol       Date:  1999-01       Impact factor: 3.501

4.  AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants.

Authors:  H Okusu; D Ma; H Nikaido
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

5.  Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae.

Authors:  T Deguchi; A Fukuoka; M Yasuda; M Nakano; S Ozeki; E Kanematsu; Y Nishino; S Ishihara; Y Ban; Y Kawada
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

6.  Bactericidal effect of antibiotics on Bartonella and Brucella spp.: clinical implications.

Authors:  J M Rolain; M Maurin; D Raoult
Journal:  J Antimicrob Chemother       Date:  2000-11       Impact factor: 5.790

7.  NorM of vibrio parahaemolyticus is an Na(+)-driven multidrug efflux pump.

Authors:  Y Morita; A Kataoka; S Shiota; T Mizushima; T Tsuchiya
Journal:  J Bacteriol       Date:  2000-12       Impact factor: 3.490

Review 8.  Brucellosis: an overview.

Authors:  M J Corbel
Journal:  Emerg Infect Dis       Date:  1997 Apr-Jun       Impact factor: 6.883

9.  Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates.

Authors:  R J Belland; S G Morrison; C Ison; W M Huang
Journal:  Mol Microbiol       Date:  1994-10       Impact factor: 3.501

10.  NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli.

Authors:  Y Morita; K Kodama; S Shiota; T Mine; A Kataoka; T Mizushima; T Tsuchiya
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

View more
  10 in total

Review 1.  Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria.

Authors:  Laura J V Piddock
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

2.  Complete genome sequence and analysis of the multiresistant nosocomial pathogen Corynebacterium jeikeium K411, a lipid-requiring bacterium of the human skin flora.

Authors:  Andreas Tauch; Olaf Kaiser; Torsten Hain; Alexander Goesmann; Bernd Weisshaar; Andreas Albersmeier; Thomas Bekel; Nicole Bischoff; Iris Brune; Trinad Chakraborty; Jörn Kalinowski; Folker Meyer; Oliver Rupp; Susanne Schneiker; Prisca Viehoever; Alfred Pühler
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

3.  Identification of essential amino acid residues of the NorM Na+/multidrug antiporter in Vibrio parahaemolyticus.

Authors:  Masato Otsuka; Makoto Yasuda; Yuji Morita; Chie Otsuka; Tomofusa Tsuchiya; Hiroshi Omote; Yoshinori Moriyama
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

Review 4.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

5.  EmmdR, a new member of the MATE family of multidrug transporters, extrudes quinolones from Enterobacter cloacae.

Authors:  Gui-Xin He; Conner Thorpe; Dennis Walsh; Robert Crow; Huizhong Chen; Sanath Kumar; Manuel F Varela
Journal:  Arch Microbiol       Date:  2011-08-07       Impact factor: 2.552

6.  Analysis of the topology of Vibrio cholerae NorM and identification of amino acid residues involved in norfloxacin resistance.

Authors:  Anil Kumar Singh; Rajen Haldar; Debabrata Mandal; Manikuntala Kundu
Journal:  Antimicrob Agents Chemother       Date:  2006-09-05       Impact factor: 5.191

7.  The TolC homologue of Brucella suis is involved in resistance to antimicrobial compounds and virulence.

Authors:  Diana M Posadas; Fernando A Martín; Julia V Sabio y García; Juan M Spera; M Victoria Delpino; Pablo Baldi; Eleonora Campos; Silvio L Cravero; Angeles Zorreguieta
Journal:  Infect Immun       Date:  2006-11-06       Impact factor: 3.441

8.  Reduced Susceptibility to Rifampicin and Resistance to Multiple Antimicrobial Agents among Brucella abortus Isolates from Cattle in Brazil.

Authors:  Rebeca Barbosa Pauletti; Ana Paula Reinato Stynen; Juliana Pinto da Silva Mol; Elaine Maria Seles Dorneles; Telma Maria Alves; Monalisa de Sousa Moura Souto; Silvia Minharro; Marcos Bryan Heinemann; Andrey Pereira Lage
Journal:  PLoS One       Date:  2015-07-16       Impact factor: 3.240

9.  Promotion of iron oxide reduction and extracellular electron transfer in Shewanella oneidensis by DMSO.

Authors:  Yuan-Yuan Cheng; Bing-Bing Li; Dao-Bo Li; Jie-Jie Chen; Wen-Wei Li; Zhong-Hua Tong; Chao Wu; Han-Qing Yu
Journal:  PLoS One       Date:  2013-11-07       Impact factor: 3.240

10.  Brucella melitensis Methionyl-tRNA-Synthetase (MetRS), a Potential Drug Target for Brucellosis.

Authors:  Kayode K Ojo; Ranae M Ranade; Zhongsheng Zhang; David M Dranow; Janette B Myers; Ryan Choi; Steve Nakazawa Hewitt; Thomas E Edwards; Douglas R Davies; Donald Lorimer; Stephen M Boyle; Lynn K Barrett; Frederick S Buckner; Erkang Fan; Wesley C Van Voorhis
Journal:  PLoS One       Date:  2016-08-08       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.